热门资讯> 正文
肿瘤研究所重申2025年指导，预测2026年收入
2026-01-12 21:36
- The Oncology Institute (TOI) on Monday reaffirmed its 2025 financial guidance and provided its preliminary 2026 outlook, expecting total revenue of $630 million to $650 million, up about 28% from the midpoint of 2025 guidance.
- The company said the increase reflects expansion of delegated contracts in Florida, higher volumes in its Dispensary segment, and new contract wins.
- Adjusted EBITDA for 2026 is projected between $0 million and $9 million, representing its first full year of adjusted EBITDA profitability as a public company at the midpoint.
- TOI also provided a longer-term view, projecting roughly 20% annual revenue growth through 2028, with potential margin expansion as the company continues to scale its asset-light capitated model and leverage SG&A.
- TOI -0.0% premarket to $4.18.
- Source: Press Release
More on The Oncology Institute
- The Oncology Institute: Making Progress
- The Oncology Institute, Inc. (TOI) Q3 2025 Earnings Call Transcript
- The Oncology Institute GAAP EPS of -$0.14 misses by $0.03, revenue of $136.6M beats by $13.97M
- TOI raises 2025 revenue outlook to $495M-$505M as pharmacy growth accelerates and adjusted EBITDA turns positive
- Seeking Alpha’s Quant Rating on The Oncology Institute
推荐文章
华盛早报 | 非农数据大超预期！首次降息或延至7月；AI恐慌交易蔓延至房地产服务板块， CBRE暴跌12%；智谱发布新模型
美股机会日报 | 经济数据强劲！美国1月非农就业大超预期，纳指期货涨至0.6%；AI应用股业绩超预期，Shopify涨超10%
资金复盘 | 北水净买入港股超48亿港元，逾7亿港元抢筹腾讯
华盛早报 | “AI威胁”波及华尔街！财富管理公司全线暴跌；豆包官宣“参战”！春节AI红包战愈演愈烈
美股机会日报 | 科技巨头迎利好？特朗普政府拟结构性豁免芯片关税；台积电1月销售额创历史新高，盘前股价涨近3%
一图看懂 | 净利大增60.7%！中芯国际Q4营收24.9亿美元，同比增长12.8%
美股机会日报 | 市场风格趋变？美银称接下来是小盘股的天下；金价重回5000美元上方，贵金属板块盘前齐升
高盛预计英伟达Q4营收达673亿美元 给出250美元目标股价
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
